D. Spittle

Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease

D. DeMeo, R. Bowler, C. Hersh, 2022, EBioMedicine.

New Pharmacological Tools to Target Leukocyte Trafficking in Lung Disease

E. Sapey, K. Belchamber, M. Hughes, 2021, Frontiers in Immunology.

Mitigating Health Risks to Reopen a Clinical Research Laboratory During the COVID-19 Pandemic: A Framework

Lauren Davis, Eloise M Walker, Alice E Jasper, 2020, JMIR research protocols.

Mitigating Health Risks to Reopen a Clinical Research Laboratory During the COVID-19 Pandemic: A Framework

E. Sapey, K. Belchamber, A. Scott, 2020, JMIR Research Protocols.

A Systematic Review and Meta-analysis of the Prevalence and Impact of Pulmonary Bacterial Colonisation in Stable State Chronic Obstructive Pulmonary Disease (COPD)

Daniella A Spittle, A. Turner, Michael N. Armitage, 2021, Biomedicines.

COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms

M. Newnham, D. Spittle, Joan Loo, 2021, Thorax.

Small Airways Disease, Biomarkers and COPD: Where are We?

A. Turner, Priyamvada S Chukowry, D. Spittle, 2021, International journal of chronic obstructive pulmonary disease.

COPD_A_280157 351..365

Daniella A Spittle, Alice M Turner, A. Turner, 2021 .

Predicting Lung Function Using Biomarkers in Alpha-1 Antitrypsin Deficiency

M. Newnham, A. Pye, Allison N. Mansfield, 2023, Biomedicines.